DK2037949T3 - Fremgangsmåde til at fremstille et "transfer-faktor" medikament - Google Patents

Fremgangsmåde til at fremstille et "transfer-faktor" medikament

Info

Publication number
DK2037949T3
DK2037949T3 DK07721839.4T DK07721839T DK2037949T3 DK 2037949 T3 DK2037949 T3 DK 2037949T3 DK 07721839 T DK07721839 T DK 07721839T DK 2037949 T3 DK2037949 T3 DK 2037949T3
Authority
DK
Denmark
Prior art keywords
medicament
transfer factor
manufacturing
lyophylisation
normalisation
Prior art date
Application number
DK07721839.4T
Other languages
English (en)
Inventor
Jan Pekarek
Original Assignee
Sevapharma A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sevapharma A S filed Critical Sevapharma A S
Application granted granted Critical
Publication of DK2037949T3 publication Critical patent/DK2037949T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK07721839.4T 2006-06-13 2007-06-12 Fremgangsmåde til at fremstille et "transfer-faktor" medikament DK2037949T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060377A CZ299296B6 (cs) 2006-06-13 2006-06-13 Lécivo transfer faktor - zpusob výroby a použití
PCT/CZ2007/000050 WO2007143957A2 (en) 2006-06-13 2007-06-12 'transfer factor' medicament - ways of manufacturing and use

Publications (1)

Publication Number Publication Date
DK2037949T3 true DK2037949T3 (da) 2012-06-18

Family

ID=38220655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07721839.4T DK2037949T3 (da) 2006-06-13 2007-06-12 Fremgangsmåde til at fremstille et "transfer-faktor" medikament

Country Status (9)

Country Link
EP (1) EP2037949B1 (da)
AT (1) ATE547111T1 (da)
CY (1) CY1113372T1 (da)
CZ (1) CZ299296B6 (da)
DK (1) DK2037949T3 (da)
ES (1) ES2383351T3 (da)
PL (1) PL2037949T3 (da)
SI (1) SI2037949T1 (da)
WO (1) WO2007143957A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338863B (es) 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
CZ2020342A3 (cs) * 2020-06-12 2021-12-22 AUMED, a.s. Způsob přípravy léčiva transfer faktor, léčivo transfer faktor, metodika testování biologické účinnosti, léková forma a její použití
CN113304172A (zh) * 2021-06-10 2021-08-27 哈尔滨圣泰生物制药有限公司 一种转移因子口服溶液的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
WO1980000790A1 (en) * 1978-10-25 1980-05-01 Benzon As Alfred Transfer factor and method for producing same
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
JPS5967226A (ja) * 1982-07-20 1984-04-16 デイミトリ・ビザ ウイルス感染処置に使用する転移因子
DE3244607A1 (de) * 1982-12-02 1984-06-07 Bezirksblutspendezentrale Plauen, DDR 9900 Plauen Verfahren zur herstellung von humanen transfer-faktor-praeparaten
JPH05508847A (ja) * 1990-07-02 1993-12-09 ナシヨナル・ジユーイツシユ・センター・フオー・イミユノロジー・アンド・レスピラトリー・メデイシン 伝達因子および使用方法
CN1093907A (zh) * 1993-12-19 1994-10-26 陕西省生物制品研究所 口服转移因子
MXPA02002171A (es) * 2002-02-28 2002-12-09 Antonio Calzada Nova Luis Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales.
CN100413534C (zh) 2003-11-03 2008-08-27 西北农林科技大学 一种治疗奶牛临床乳房炎的生物性免疫制剂及其制作方法
CN1654477A (zh) 2004-02-13 2005-08-17 北京世纪昭宝转移因子研究中心 制备转移因子工艺方法－加热法

Also Published As

Publication number Publication date
WO2007143957B1 (en) 2008-06-26
SI2037949T1 (sl) 2012-07-31
CZ2006377A3 (cs) 2007-07-04
CZ299296B6 (cs) 2008-06-11
ATE547111T1 (de) 2012-03-15
EP2037949B1 (en) 2012-02-29
EP2037949A2 (en) 2009-03-25
ES2383351T3 (es) 2012-06-20
WO2007143957A3 (en) 2008-05-08
CY1113372T1 (el) 2016-06-22
PL2037949T3 (pl) 2012-10-31
WO2007143957A2 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
WO2007118235A3 (en) Filtration system for preparation of fluids for medical applications.
BRPI0821027B8 (pt) 4-(4-ciano-2-tioaril)di-hidropirimidinonas para tratamento e/ou prevenção de lesões do pulmão e do sistema cardiovascular, seu processo de preparação e seu uso, e medicamento
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
NZ612105A (en) Human milk oligosaccharides for modulating inflammation
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
BR112014031730A2 (pt) entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1
BRPI0804623B8 (pt) uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
DK2037949T3 (da) Fremgangsmåde til at fremstille et "transfer-faktor" medikament
CN204484535U (zh) 一种疾病预防控制床
SE0301577L (sv) Lösning med låg natriumhalt
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
BR112014005221A2 (pt) uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes
BR112022000944A2 (pt) Derivados de di-hidropirimidina e seus usos no tratamento de infecção por hbv ou de doenças induzidas por hbv
BR112022001564A2 (pt) Derivados de di-hidropirimidina e seus usos no tratamento de infecção por hbv ou de doenças induzidas por hbv
CN201692228U (zh) 一种护士用臂套
Kalivas et al. Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders
Kloos Crisantaspase/pegaspargase
CN105395538A (zh) 一种治疗急性上呼吸道感染的药物组合物
Glatstein Atropa belladonna
UA131890U (uk) Спосіб лікування коморбідних бактеріальних інфекцій у хворих на хронічну хворобу нирок vд стадії
Erol Zoledronic acid
Yuhico Development of multi-drug resistant Pseudomonas aeruginosa: case report
MD3446F1 (en) Method of HIV infection treatment